Active, not recruiting
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP
NCT06079359
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
- Locations
-
- Research Site Baltimore, Maryland, United States
- Research Site Kansas City, Missouri, United States
- Research Site Durham, North Carolina, United States
- Research Site Nedlands, Australia